Bio- and Pharmaanalysis

Predictive, preventive, personalized and participatory medicine, known as P4, is the healthcare of the future.

Martin Jönsson CEO And Johan Sandin CSO Alzecure Pharma

Some sunscreens offer very limited protection against dangerous sunrays and may even be harmful.

The new research project Optima aims to improve treatment for patients with prostate, breast and lung cancer through artificial intelligence.

Samsung Biologics is a fully integrated CDMO.

Artistic depiction of human mitochondrial ribonuclease P. A rendering of the three-dimensional model of mtRNase P is depicted in the foreground with protein subunits in grey and RNA in red, and the typical cristae-structure of mitochondrial membranes and associated protein complexes are depicted in the background.

Zebrafish infected with fluorescent bacteria, Mycobacterium abscessus, shown in red.

For the first time the process by which cells acquire spatial nonuniformities on their surfaces has been identified. (symbolic image)

Unfold for details of your consent

Stand vom 23.03.2021

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.